Effects of Adipates, Phthalates, and Fibrates on Liver Enzymes and Peroxisomes in a Variety of Mammalian Species

  • J. C. Lhuguenot
Conference paper
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 12)

Abstract

More than 20 years ago, Hess et al. (1965) published their first paper on peroxisome proliferation in rat liver induced by Clofibrate, a hypolipidemic drug. During these past 22 years, peroxisome proliferation has become an intensive field of research field. The quite strong link between peroxisome proliferation and subsequent liver cancer is probably one of the major reasons for this enormous amount of work.

Keywords

Butyl Phthalate Carnitine Chlorpromazine DEHP 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cornu MC, Lhuguenot JC, Mitchell AM, Elcombe CR (1987) Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) adipate using a primary rat hepatocytes culture. Tox Lett (in the press)Google Scholar
  2. Elcombe CR, Mitchell AM (1986) Peroxisome proliferation due to di-(2-ethylhexyl) phthalate. Species differences and possible mechanisms. Environ Health Persp 70:211–219CrossRefGoogle Scholar
  3. Elcombe CR, Batten PL, Jackson SJ, Pratt IS, Rhodes C (1983) Comparative toxicity of di-(2-ethylhexyl) phthalate (DEHP) in rats and marmosets. Toxicologist 3:507Google Scholar
  4. Hashimoto T (1987) Comparison of enzymes of lipid β-oxidation in peroxisomes and mitochondria. In: Fahimi HD, Sies M (eds) Peroxisomes in biology and medicine. Springer, Berlin Heidelberg New York pp 97–103CrossRefGoogle Scholar
  5. Hess R, Staubli W, Riess W (1965) Nature of hepatomegaly effect produced by ethyl-chloro-phenoxy-isobutyrate in the rat. Nature 208:856–858PubMedCrossRefGoogle Scholar
  6. Laignelet L, Joffrain A, Riviere JL, Lhuguenot JC (1986) Induction du cytochrome P-450 et de la prolifération de peroxysomes hépatiques par le prochloraz chez le rat. J Tox Clin Exp 6:198Google Scholar
  7. Lake BG, Gangolli SD, Grasso P, Lloyd AG (1975) Studies of the hepatic effects of orally administratered di-(2-ethyl-hexyl) phthalate in the rat. Tox Appl Pharmacol 32:355–367CrossRefGoogle Scholar
  8. Lhuguenot JC, Elcombe CR (1984) Variation selon l’espèce des phénomènes de conjugaison lors du métabolisme du di-(ethyl-2-hexyle) phtalate. Sci Alim 43:227–232Google Scholar
  9. Marty V (1987) Modifications ultrastructurales des peroxysomes et des mitochondries chez le rat, lors du traitement par le DEHA et l’acide 2-ethyl hexanoïque. Diplôme d’Etudes Approfondies, Université de Bourgogne, Dijon (to be published)Google Scholar
  10. Mitchell AM, Lhuguenot JC, Bridges JW, Elcombe CR (1985) Identification of the proximate peroxisome proliferator(s) derived from di-(2-ethylhexyl) phthalate. Tox Appl Pharmacol 79:23–32CrossRefGoogle Scholar
  11. Mitchell AM (1985) Hepatic peroxisome proliferation: mechanisms and species differencies. PhD Thesis, University of Surrey, GuilfordGoogle Scholar
  12. Ohno S (1981) Histochemical studies on peroxisomes of rat livers during DEHP administration after withdrawal on thick sections by means of light microscopy and high voltage electron microscopy. Acta Histochem Cytochem 14–2:126–142CrossRefGoogle Scholar
  13. Price SC, Hinton RH, Hall DE, Grasso P, Bridges JW (1982) Accumulation of lipid rich-lysosomes in the livers and kidneys of rats treated with hypolipidaemic agents. Biochem Soc Trans 10:244–248Google Scholar
  14. Price SC, Hall DE, Hinton RH (1985) Lipid accumulation in the livers of chlorpromazine treated rat does not induce peroxisome proliferation. Tox Lett 25:11–18CrossRefGoogle Scholar
  15. Reddy JK, Lalwani ND (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidaemic drugs and industrial plasticizers to humans. Crit Rev Toxicol 12:1–58PubMedCrossRefGoogle Scholar
  16. Reddy JK, Reddy KM, Usman MI, Lalwani ND, Rao MS (1986) Comparison of hepatic peroxisome effect and its implication for hepatocarcinogenicity of phthalate and adipate esters with a hypolipidaemic drug. Environ Health Persp 65:317–327Google Scholar
  17. Weil A, Caldwell J (1987) Species differencies in the chirality of the carbonyl reduction of [14C]- fenofibrate in laboratory animals and humans. Drug Metab Dispos (submitted)Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • J. C. Lhuguenot
    • 1
  1. 1.Départment de Biochimie et Toxicologie Alimentaires, Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l’AlimentationCampus UniversitaireDijonFrance

Personalised recommendations